MetLife CEO Michel Khalaf sells 187,425 shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
MetLife Inc. President & CEO Michel Khalaf exercised options for 248,729 common shares on November 10, 2026, in four tranches with exercise prices of $44.65, $45.50, $46.85 and $47.58 per share. He sold 187,425 common shares the same day at a weighted-average price of $102.9676 per share. MetLife said the sale covered only shares needed to pay the option exercise price, related tax obligations and fees; the reported sale prices ranged from $102.59 to $103.235, inclusive. No Rule 10b5-1 plan is reported.
Insider Trade Summary
Exercise and sale activity reported; no spread calculated
Exercise and Sale
9 txns
Insider
Khalaf Michel
Role
President & CEO
Sold
187,425 shs ($19.30M)
Approx. gross sale proceeds
$19.30M
Approx. exercise cost
$11.48M
Share of Position Sold
19.8%
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Employee Stock Option (Right to Buy) F3, F4 | 28,817 | $0.00 | $0.00 |
| Exercise | Employee Stock Option (Right to Buy) F5 | 34,608 | $0.00 | $0.00 |
| Exercise | Employee Stock Option (Right to Buy) F6 | 90,726 | $0.00 | $0.00 |
| Exercise | Employee Stock Option (Right to Buy) F7 | 94,578 | $0.00 | $0.00 |
| Exercise | Common Stock | 28,817 | $46.85 | $1.35M |
| Exercise | Common Stock | 34,608 | $45.50 | $1.57M |
| Exercise | Common Stock | 90,726 | $44.65 | $4.05M |
| Exercise | Common Stock | 94,578 | $47.58 | $4.50M |
| Sale | Common Stock F1, F2 | 187,425 | $102.9676 | $19.30M |
Holdings After Transaction:
Employee Stock Option (Right to Buy) — 0 options (Direct);
Common Stock — 759,013 shares (Direct)
Holdings Before and After:
Employee Stock Option (Right to Buy), 248,729 to 0 options (Direct);
Common Stock, 697,709 to 759,013 shares (Direct)
Footnotes (7)
- F1. The reporting person sold only the number of shares of MetLife, Inc.'s common stock necessary to pay the exercise price of the options exercised on November 10, 2026, and related tax obligations and fees.
- F2. The price reported is the weighted average price of the aggregate number of shares sold in multiple open market transactions. The shares were sold at prices between $102.59 to $103.235, inclusive. The reporting person undertakes to provide to the staff of the SEC, MetLife, Inc., or a security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price.
- F3. Includes 3,073 stock options previously added to the reporting person's award through an adjustment to maintain the intrinsic value of the stock options in light of the distribution by MetLife, Inc. to its shareholders of Brighthouse Financial, Inc. common stock. The reporting person did not receive shares of Brighthouse Financial, Inc. common stock on account of the stock options.
- F4. The options became exercisable in three equal installments on February 28, 2018, 2019, and 2020.
- F5. The options became exercisable in three installments on March 2, 2019, 2020 and 2021.
- F6. The options became exercisable in three installments on February 26, 2020, 2021 and 2022.
- F7. The options become exercisable in equal installments on each of the first three anniversaries of the grant date.
Key Figures
Options exercised for common shares: 248,729 shares
Option tranche and exercise price: 28,817 options at $46.85 per share
Option tranche and exercise price: 34,608 options at $45.50 per share
+5 more
8 metrics
Options exercised for common shares
248,729 shares
November 10, 2026
Option tranche and exercise price
28,817 options at $46.85 per share
November 10, 2026
Option tranche and exercise price
34,608 options at $45.50 per share
November 10, 2026
Option tranche and exercise price
90,726 options at $44.65 per share
November 10, 2026
Option tranche and exercise price
94,578 options at $47.58 per share
November 10, 2026
Common shares sold
187,425 shares
November 10, 2026
Weighted-average sale price
$102.9676 per share
Sale reported for November 10, 2026
Reported sale price range
$102.59 to $103.235 per share
Inclusive range for the sale
Key Terms
Employee Stock Option (Right to Buy), weighted average price, exercise price, open market transactions
4 terms
Employee Stock Option (Right to Buy) technical
"Employee Stock Option (Right to Buy)"
weighted average price financial
"The price reported is the weighted average price"
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
exercise price financial
"pay the exercise price of the options exercised"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
open market transactions financial
"aggregate number of shares sold in multiple open market transactions"
Open market transactions are the buying and selling of a company’s shares or other securities conducted on public exchanges or through the wider market rather than through private deals or negotiated placements. They matter to investors because these trades change supply and demand in real time—like shoppers affecting a store’s inventory—and so can move prices, signal management or investor sentiment, affect liquidity, and alter ownership stakes that influence future returns and risk.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How many MET options did Michel Khalaf exercise, and at what prices?
Michel Khalaf exercised options for 248,729 MET common shares on November 10, 2026. The four tranches were 28,817 options at $46.85, 34,608 at $45.50, 90,726 at $44.65 and 94,578 at $47.58 per share.
AI-generated analysis. How Rhea-AI works. Not financial advice.
